Combination therapy involving radiofrequency ablation and targeted chemotherapy with bevacizumab plus paclitaxel and cisplatin in a rabbit VX2 lung tumor model

Combination therapy involving radiofrequency ablation and targeted chemotherapy with bevacizumab plus paclitaxel and cisplatin in a rabbit VX2 lung tumor model

Abstract Objective Radiofrequency ablation (RFA) is less effective for large tumors > 3 cm in diameter. Various studies of combination therapy using RFA and other treatments have been conducted to improve the results of RFA treatment of lung tumors, survival was extended in a tumor model when RFA...

Full description

Bibliographic Details
Main Authors: Ai Ueki, Tomohisa Okuma, Shinichi Hamamoto, Ken Kageyama, Kazuki Murai, Yukio Miki
Format: Article
Language:English
Published: BMC 2018-04-01
Series:BMC Research Notes
Subjects:
Radiofrequency ablation
Rabbit
Lung
Chemotherapy
VX2 tumor
Online Access:http://link.springer.com/article/10.1186/s13104-018-3358-x

Similar Items

Similar Items